Hematologic Cancer
📧 Sign up to get email alerts when something new happens for Hematologic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Improving Patient Experience: BMBA [NA]
The BMBA clinical trial sponsored by Thomas Jefferson University has completed, but no specific results are provided in the update.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.
Clinical trial update describes an access protocol for infusing CD34+ enriched, T cell–depleted hematopoietic stem cell grafts; the study is…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer [NA]
A clinical trial is being developed to test an intervention that combines hypnosis and virtual reality to support patients with hematologic …
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Pulsed Electromagnetic Fields in Preventing Physical Deconditioning in Patients Undergoing Prolonged Hospitalization [NA]
This clinical trial update shows the Pulsed Electromagnetic Fields study to prevent physical deconditioning in patients undergoing prolonged…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Intervention for Fatigue in HCT Recipients [NA]
Massachusetts General Hospital is conducting a clinical trial to test an intervention for fatigue in hematopoietic stem cell transplant reci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Financial Navigation Study Among Young Adult Blood Cancer Survivors [NA]
A completed clinical trial update describing the status of a study examining financial navigation support for young adult survivors of hemat…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Stop Addiction Stigma [NA]
This is a completed clinical trial update (NCT06582030) from Ohio State University Comprehensive Cancer Center, related to hematologic malig…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Coverage and Cost-of-Care (CC) Links- Financial Navigation Program [NA]
Completed status reported for a clinical trial evaluating a financial navigation program to help patients with hematologic cancer manage cov…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation [NA]
A clinical trial is evaluating photobiomodulation to prevent oral mucositis and improve functional outcomes during hematopoietic stem cell t…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT [Phase 2]
A Phase 2 trial evaluates MIT-001 for prevention of oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: The Effect of an Online ACT Intervention on Meaning-Making Process in Cancer Patients Following Hematopoietic Cell Transplantation [NA]
This clinical trial update describes an online Acceptance and Commitment Therapy intervention to aid meaning-making in cancer patients after…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 [Phase 2]
Phase 2 trial evaluating crizotinib in patients with ALK, MET, or ROS1 alterations has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: CLAGE Sequential With Flu-Bu Conditioning for Refractory Acute Leukemia [Phase 2]
Phase 2 clinical trial update for CLAGE sequential conditioning with Flu-Bu in refractory acute leukemia undergoing allogeneic stem cell tra…
-
CLINICAL_TRIALS withdrawal · 2023-08-14Clinical Trial Update: CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients [Phase 4]
Phase 4 trial evaluating ceftolozane-tazobactam for empiric anti-bacterial treatment in neutropenic fever among hematology patients was with…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating beclomethasone dipropionate to prevent acute graft-versus-host disease in patients undergoing donor stem c…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial investigating rituximab to prevent acute graft-versus-host disease in donor stem cell transplantation for hematologic cancers;…
-
CLINICAL_TRIALS research · 2018-06-28Clinical Trial Update: Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy [NA]
The document notes the completion of a clinical trial testing magnetic acupressure to reduce pain in cancer patients undergoing bone marrow …
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Improved Outcome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients by Reducing Caregiver Distress [NA]
A completed clinical trial found that reducing caregiver distress improves outcomes for patients undergoing allogeneic hematopoietic stem ce…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer [Phase 2]
Phase 2 trial update examining immune response after stem cell transplant in HIV-positive patients with hematologic cancer; the study status…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 clinical trial updating the use of tacrolimus and mycophenolate mofetil to prevent graft-versus-host disease in patients undergoing …
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy [Phase 3]
Phase 3 trial evaluating whether adding olanzapine to standard antiemetic therapy improves prevention of chemotherapy-induced nausea and vom…
-
CLINICAL_TRIALS research · 2017-02-17Clinical Trial Update: Patient-Reported Outcomes Integrated in the Follow-up of Patients With Hematological Cancer [NA]
This clinical trial update describes integrating patient-reported outcomes into the follow-up care of patients with hematologic cancer, spon…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders [NA]
A completed clinical trial evaluating a conditioning regimen of fludarabine phosphate, melphalan, total-body irradiation, and donor stem cel…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant [NA]
A completed clinical trial update from Fred Hutchinson Cancer Center on supportive care for patients with hematologic cancers undergoing hem…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor [Phase 1]
This document provides an update on a Phase 1 trial evaluating irradiated donor lymphocyte infusion in patients with relapsed or refractory …